CT-guided radioactive
125I brachytherapy
Clinical study
Colorectal cancer
Lung oligometastases
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
26 Feb 2024
26 Feb 2024
Historique:
received:
30
08
2023
accepted:
16
02
2024
medline:
26
2
2024
pubmed:
26
2
2024
entrez:
25
2
2024
Statut:
epublish
Résumé
To evaluate the safety and effectiveness of computed tomography (CT)-guided radioactive Data for 144 LOs from 70 CRC patients who underwent CT-guided RISB were retrospectively analyzed. The primary endpoints were progression-free survival (PFS) and overall survival (OS), and the secondary endpoints were technical success, local control rate (LCR), and complications. Kaplan-Meier method was used for survival analysis. Cox model was used to identify the independent predictors of poor prognosis. The RISB procedures were successfully performed in all patients, and the success rate was 100%. The median follow-up was 27.8 months. The median PFS was 10.0 months (95% CI: 8.9-11.1) and the 1- and 2-year PFS rates were 32.9% and 5.9%, respectively. On multivariate analysis, serum carcinoembryonic antigen (CEA) ≤ 15 ng/ml (P = 0.048), middle-high differentiated pathological classification (P = 0.015), primary TNM stages I-III (P = 0.001), LO number ≤ 2 (P < 0.001) and cumulative gross tumor volume (GTV) ≤ 40 cm RISB for LO from CRC is safe and effective, and serum CEA, TNM stage, LO number, cumulative GTV, and system treatments should be emphasized for long OS.
Identifiants
pubmed: 38403626
doi: 10.1186/s12885-024-12013-2
pii: 10.1186/s12885-024-12013-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
265Subventions
Organisme : Major Science and Technology Projects of Henan Province in 2022
ID : No:221100310100
Organisme : Henan Province Science and Technology Research Project in 2023
ID : No:232102311132
Informations de copyright
© 2024. The Author(s).
Références
Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021. https://doi.org/10.1097/CM9.0000000000001474 .
doi: 10.1097/CM9.0000000000001474
pubmed: 35108230
pmcid: 8812648
Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019. https://doi.org/10.1136/gutjnl-2018-317124 .
doi: 10.1136/gutjnl-2018-317124
pubmed: 31836611
Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995. https://doi.org/10.1200/JCO.1995 .
doi: 10.1200/JCO.1995
pubmed: 7738620
Yang G, Wang G, Sun J, et al. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: a systematic review and meta-analysis based on 22 studies. Int J Surg. 2021. https://doi.org/10.1016/j.ijsu.2021.105896 .
doi: 10.1016/j.ijsu.2021.105896
pubmed: 34920147
pmcid: 7901278
Salah S, Watanabe K, Park JS, et al. Repeated resection of colorectal cancer pulmonary oligometastases: pooled analysis and prognostic assessment. Ann Surg Oncol. 2013. https://doi.org/10.1245/s10434-012-2860-y .
doi: 10.1245/s10434-012-2860-y
pubmed: 23334254
Lehrer EJ, Singh R, Wang M, et al. Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis. JAMA Oncol. 2021. https://doi.org/10.1001/jamaoncol.2020.6146 .
doi: 10.1001/jamaoncol.2020.6146
pubmed: 33237270
Owen D, Olivier KR, Mayo CS, et al. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiat Oncol. 2015. https://doi.org/10.1186/s13014-015-0340-9 .
doi: 10.1186/s13014-015-0340-9
pubmed: 25927334
pmcid: 4422039
Ding XF, Huang TB, Gao Y, et al. Permanent 125I prostate brachytherapy for castration-resistant prostate cancer. Int J Urol. 2019. https://doi.org/10.1111/iju.13866 .
doi: 10.1111/iju.13866
pubmed: 30515888
Zhao Z, Yao W, Zhang T, et al. Computed tomography-guided implantation of 125I radioactive seeds in patients with malignant airway compression induced by advanced lung cancer: effectiveness and safety in 40 patients. J Contemp Brachytherapy. 2020. https://doi.org/10.5114/jcb.2020.98113 .
doi: 10.5114/jcb.2020.98113
pubmed: 33299434
pmcid: 7701924
Fan T, Zhou JY. Computed tomography-guided
doi: 10.29271/jcpsp.2020.04.364
pubmed: 33036681
Zhang QZ, Li GL, Shang JB, Ren YM, Xie JL. Clinical study of a 125I particle-integrated esophageal covered stent and hyperbaric oxygen in the treatment of advanced esophageal cancer. Rev Esp Enferm Dig. 2021. https://doi.org/10.17235/reed.2020.7377/2020 .
doi: 10.17235/reed.2020.7377/2020
pubmed: 33562987
Jiao D, Xu K, Mukhiya G, et al. Brachytherapy drainage catheter and chemotherapy for unresectable pancreatic carcinoma combined with obstructive jaundice. Front Oncol. 2022. https://doi.org/10.3389/fonc.2022.941336 .
doi: 10.3389/fonc.2022.941336
pubmed: 36686739
pmcid: 9762551
The Radiation Oncology Branch of the Chinese Medical Association, the Radiation Oncology Branch of the Chinese Medical Association, and the Cancer Radiation Therapy Professional Committee of the Chinese Anti Cancer Association. Chinese guidelines for radiotherapy of esophageal cancer (2021 Edition). Int J Oncol. 2022. https://doi.org/10.3760/cma.j.cn371439-20211021-00002 .
Spaander MC, Baron TH, Siersema PD, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2016. https://doi.org/10.1055/s-0042-114210 .
doi: 10.1055/s-0042-114210
pubmed: 27626318
Wang Z, Zhao Z, Lu J, et al. A comparison of the biological effects of
doi: 10.1371/journal.pone.0133728
pubmed: 26720814
pmcid: 4699924
Zhou X, Zhang W, Dou M, et al.
doi: 10.1016/j.canlet.2021.10.014
pubmed: 36493901
Zhang W, Li J, Li R, Zhang Y, Han M, Ma W. Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non-small cell lung cancer-A meta-analysis. Brachytherapy. 2018. https://doi.org/10.1016/j.brachy.2017.11.015 .
doi: 10.1016/j.brachy.2017.11.015
pubmed: 30316723
pmcid: 6615564
Nag S. Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations. Semin Urol Oncol. 2000;18(2):133–6.
pubmed: 10875454
Liu Y, Zhang C, Xu K, Wu K, Han X, Jiao D. 125I brachytherapy: a useful treatment to control painful osteoblastic bone metastases. Clin Transl Oncol. 2023. https://doi.org/10.1007/s12094-022-03025-0 .
doi: 10.1007/s12094-022-03025-0
pubmed: 38123874
pmcid: 10811109
Min SJ, Jang HJ, Kim JH. Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review. Oncotarget. 2016. https://doi.org/10.18632/oncotarget.8425 .
doi: 10.18632/oncotarget.8425
pubmed: 27863404
pmcid: 5503650
Zhang S, Chen Q, Wang Q. The use of and adherence to CTCAE v3.0 in cancer clinical trial publications. Oncotarget. 2016. https://doi.org/10.18632/oncotarget.11576 .
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. https://doi.org/10.3322/caac.21492 .
doi: 10.3322/caac.21492
pubmed: 30207593
Morris VK, Kennedy EB, Baxter NN, et al. Treatment of metastatic colorectal cancer: ASCO guideline. J Clin Oncol. 2023. https://doi.org/10.1200/JCO.22.01690 .
doi: 10.1200/JCO.22.01690
pubmed: 38113419
Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016. https://doi.org/10.1093/annonc/mdw235 .
doi: 10.1093/annonc/mdw235
pubmed: 27573561
pmcid: 5091322
Tampellini M, Ottone A, Bellini E, et al. The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. Oncologist. 2012. https://doi.org/10.1634/theoncologist.2012-0142 .
doi: 10.1634/theoncologist.2012-0142
pubmed: 22956535
pmcid: 3500365
Li J, Zhang L, Xie Q, Wang W, Hua Y, Sun Z. Comparison of clinical efficacy and complications of 125I seed brachytherapy and stereotactic body radiation therapy for recurrent pulmonary metastases from colorectal carcinoma. J Contemp Brachytherapy. 2018. https://doi.org/10.5114/jcb.2018.77956 .
doi: 10.5114/jcb.2018.77956
pubmed: 30479626
pmcid: 6251445
Heelan RT, Hilaris BS, Anderson LL, et al. Lung tumors: percutaneous implantation of I-125 sources with CT treatment planning. Radiology. 1987. https://doi.org/10.1148/radiology.164.3.3615870 .
doi: 10.1148/radiology.164.3.3615870
pubmed: 3615870
Agolli L, Bracci S, Nicosia L, Valeriani M, De Sanctis V, Osti MF. Lung metastases treated with stereotactic ablative radiation therapy in oligometastatic colorectal cancer patients: outcomes and prognostic factors after long-term follow-up. Clin Colorectal Cancer. 2017. https://doi.org/10.1016/j.clcc.2016.07.004 .
doi: 10.1016/j.clcc.2016.07.004
pubmed: 27522627
Wang X, Zamdborg L, Ye H, Grills IS, Yan D. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer. BMC Cancer. 2018. https://doi.org/10.1186/s12885-018-4865-9 .
doi: 10.1186/s12885-018-4865-9
pubmed: 30594176
pmcid: 6311060
Carvajal C, Navarro-Martin A, Cacicedo J, Ramos R, Guedea F. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results. J BUON. 2015;20(1):158–65.
pubmed: 25778311
Qiu H, Katz AW, Chowdhry AK, et al. Stereotactic body radiotherapy for lung metastases from colorectal cancer: prognostic factors for disease control and survival. Am J Clin Oncol. 2018. https://doi.org/10.1097/COC.0000000000000220 .
doi: 10.1097/COC.0000000000000220
pubmed: 28930776
Filippi AR, Badellino S, Ceccarelli M, et al. Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study. Int J Radiat Oncol Biol Phys. 2015. https://doi.org/10.1016/j.ijrobp.2014.10.046 .
doi: 10.1016/j.ijrobp.2014.10.046
pubmed: 26972651
Wang G, Zhang F, Yang B, et al. Feasibility and clinical value of CT-guided (125)I brachytherapy for bilateral lung recurrences from colorectal carcinoma. Radiology. 2016. https://doi.org/10.1148/radiol.2015150641 .
doi: 10.1148/radiol.2015150641
pubmed: 28005489
pmcid: 5019139